维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

13篇 您的检索式：作者名="Lobo LA"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Temperature- induced changes in the lipopolysaccharide of Yersinia pestis affect plasminogen activation by the pla surface protease 显示文摘	Suomalainen M Lobo LA Brandenburg K	2010	Infect Immun2010，78，6：	1
	2	Pregnancy after solid organ transplantation: a guide for obstetric management显示文摘	Deshpande NA Coscia LA Gomez Lobo V	2013	Rev Obstet Gyneeol2013，6，11：	1
	3	Adhesive properties of the purified plasminogen activator Pla of Yersinia pestis 显示文摘	Lobo LA	2006	FEMS Microbiol Lett2006，262，2：	1
	4	Nutrients and energy intake assessment in the critically ill patient on enteral nutritional therapy显示文摘	Abilés J Lobo G Pérez de la Cruz A		0，，02：	1
	5	Nutrients and energy intake assessment in the critically ill patient on enteral nutritional therapy 显示文摘	Abiles J Lobo G Perez de la Cruz A	2005	NutrHosp2005，20，2：	1
	6	Adhesive properties of the purified plasminogen activator Pla of Yersinia pestis 显示文摘	Lobo LA	2006	FEMS Microbiol Lett2006，262，2：	1
	7	Nutrients and energy intake assessment in the critically ill patient on enteral nutritional therapy显示文摘	Abiles J Lobo G Perez de la Cruz A	2005	Nutr Hosp2005，20，2：	1
	8	Adhesive properties of the purified plasminogen activa- tor Pla of Yersinia pestis 显示文摘	Lobo LA	2006	FEMS Microbiol Lett2006，262，2：	1
	9	In vitro evaluation of caries inhibition promoted by self-etching adhesive systems containing antibacterial agents 显示文摘	Lobo MM Gon:alves RB Pimenta LA	2005	J Biomed Mater Res B Appl Biomater2005，75，1：	1
	10	Adhesive Properties of the Purified Plasminogen Activator Pla of Yersinia pestis 显示文摘	Lobo LA	2006	FEMS Microbiol Lett2006，262，2：	1
	11	Localization of the mandibular canal in brachycephalic dogs using computed tomography 显示文摘	Martinez LA Gioso MA Lobos CM	2009	J Vet Dent2009，26，3：	1
	12	WJD 5^(th) Anniversary Special Issues(2): Type 2 diabetes Structured SMBG in early management of T2DM: Contributions from the St Carlos study显示文摘Diabetes mellitus type 2(T2DM)is a global pandemic that will affect 300 million people in the next decade.It has been shown that early and aggressive treatment of T2DM from the onset decreases complications,and the patient’s active role is necessary to achieve better glycemic control.In order to achieve glycemic control targets,an active attitude in patients is needed,and selfmonitoring of blood glucose(SMBG)plays a significant role.Nowadays,SMBG has become an important component of modern therapy for diabetes mellitus,and is even more useful if it is performed in a structured way.SMBG aids physicians and patients to achieve a specific level of glycemic control and to prevent hypoglycemia.In addition,SMBG empowers patients to achieve nutritional and physical activity goals,and helps physicians to optimize the different hypoglycemic therapies as demonstrated in the St Carlos study.This article describes the different ways of using this educational and therapeutic tool from the medical point of view as well as from the patient’s perspective.	Teresa Ruiz Gracia Nuria García de la Torre Lobo Alejandra Durán Rodríguez Hervada Alfonso L Calle Pascual	2014	World Journal of Diabetes2014，5，4：	1
	13	Localizationof the mandibular canal in brachycephalic dogs using computedtomography 显示文摘	Martinez LA Gioso MA Lobos CM Pinto A C	2009	J Vet Dent2009，26，3：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费